Optimistic Buy Rating for Acurx Pharmaceuticals Driven by Promising Ibezapolstat Progress and Strategic Financial Planning

TipRanksDec 12 15:55 · Ratings

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

AccesswireDec 12 00:00

HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

BenzingaDec 11 01:25 · Ratings

Acurx Pharmaceuticals Analyst Ratings

BenzingaDec 11 01:24 · Ratings

Acurx Pharmaceuticals Shares Are Trading Higher After the Company Announced Its Preparing to Advance to Phase 3 Clinical Trials to Treat Patients With C. Difficile Infection.

BenzingaDec 10 04:14

Express News | Acurx Pharmaceuticals Inc - FDA Provides Positive Feedback on Acurx's Cmc Plan for Phase 3

BreakingsDec 9 21:39